Post‐tuberculosis respiratory impairment in Gambian children and adolescents: A cross‐sectional analysis
Esin Nkereuwem, Schadrac C. Agbla, Bintou Njai, Victory Fabian Edem, Muhammed Lamin Jatta, Olumuyiwa Owolabi, Uma Masterton, Fatoumatta Jah, et al. (16 authors)
Pediatric Pulmonology · 2024-04
Abstract
BACKGROUND: Although post-tuberculosis lung disease (PTLD) is a known consequence of pulmonary tuberculosis (pTB), few studies have reported the prevalence and spectrum of PTLD in children and adolescents. METHODS: Children and adolescent (≤19 years) survivors of pTB in the Western Regions of The Gambia underwent a respiratory symptom screening, chest X-ray (CXR) and spirometry at TB treatment completion. Variables associated with lung function impairment were identified through logistic regression models. RESULTS: Between March 2022 and July 2023, 79 participants were recruited. The median age was 15.6 years (IQR: 11.8, 17.9); the majority, 53/79 (67.1%), were treated for bacteriologically confirmed pTB, and 8/79 (10.1%) were children and adolescents living with HIV. At pTB treatment completion, 28/79 (35.4%) reported respiratory symptoms, 37/78 (47.4%) had radiological sequelae, and 45/79 (57.0%) had abnormal spirometry. The most common respiratory sequelae were cough (21/79, 26.6%), fibrosis on CXR (22/78, 28.2%), and restrictive spirometry (41/79, 51.9%). Age at TB diagnosis over ten years, undernutrition and fibrosis on CXR at treatment completion were significantly associated with abnormal spirometry (p = .050, .004, and .038, respectively). CONCLUSION: Chronic respiratory symptoms, abnormal CXR, and impaired lung function are common and under-reported consequences of pTB in children and adolescents. Post-TB evaluation and monitoring may be necessary to improve patient outcomes.
MeSH terms
- Medicine
- Spirometry
- Tuberculosis
- Pediatrics
- Cross-sectional study
- Internal medicine
- Respiratory system
- Restrictive lung disease
- Respiratory disease
- Pulmonary function testing
- Lung